You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
格隆汇港股聚焦(5.04)︱中梁控股前4个月销售279亿 亚盛医药核心在研新药获得美国FDA孤儿药资格认定
格隆汇 05-04 22:49

【业绩预告】

侨洋国际控股(08070.HK)预计一季度盈转亏至220万港元

树熊金融集团(08226.HK)料首季盈利大幅减

高科桥(08465.HK)预计一季度录得重大净利润减幅约100%

华泰瑞银(08006.HK)一季度预亏100万至300万港元

华康生物医学(08622.HK)首季预亏约275.3万元

汇友生命科学(08088.HK)预计首季亏损减少30%至40%

开源控股(01215.HK)料中期亏损将大幅增加

凯富善集团控股(08512.HK)一季度预盈约500万至800万港元

WT集团(08422.HK)料前9月税后净亏损约430万至480万港元

彭顺国际(06163.HK)料中期期间溢利净额减少多于70%

高奥士国际(08042.HK)预期一季度由盈转亏170万港元

杰地集团(08313.HK)首季预盈约20万新加坡元

裕兴科技(08005.HK)预计一季度由盈转亏7600万港元

智纺国际控股(08521.HK)预计一季度盈转亏至400万港元

怡园酒业(08146.HK)预计一季度净亏损减少31%

智易控股(08100.HK)预计一季度亏损不超500万港元

【运营数据】

中梁控股(02772.HK):1至4月累计实现合约销售额约279亿元

建业地产(00832.HK)4月物业合同销售额增加26.7%至75.03亿元

景瑞控股(01862.HK)4月实现合约签约销售额约11.38亿元

明发集团(00846.HK)一季度销售额14.9亿元 同比下降29%

【诉讼处罚】

中国环保科技(00646.HK):撤销Sure Fast的临时禁制令传票

【股权变更】

星宇控股(02346.HK):控股股东吕竹风所持16.6%公司股份被强制出售

【股本重组】

财讯传媒(00205.HK)"20合1"并股今日生效

【并购出售】

珠江船务(00560.HK)拟2.33亿港元收购新世界第一渡轮服务60%股权

远大医药(00512.HK)与CDH斥1.5亿美元进一步认购Grand Pharma SpherePte股份

【增发供股】

新世界发展(00017.HK)5月04日因董事行使购股权增发1067.56万股

【重大事项】

亚盛医药(06855.HK):HQP1351获得美国FDA孤儿药资格认定

石药集团(01093.HK)肝病用药门冬氨酸鸟氨酸注射液获药品注册批件

"卫星+5G"入国家新基建将激励车联网高速发展 中播控股(00471.HK)新商业计划具先发优势

神州数字(08255.HK):CB International拟向基金增发3619.91万股

德昌电机控股(00179.HK):预期将就商誉及其他无形资产减值约8亿美元

胜捷企业(06090.HK):西雅卓源重建工程竣工后估值增加2.84亿新元

金利通(08256.HK)与中国信息数据协会城市运营部订立谅解备忘录 继续停牌

【回购注销】

东阳光药(01558.HK)5月4日耗资6415.96万港元回购221.74万股

兖州煤业股份(01171.HK)5月4日耗资3403.57万港元回购600万股H股

复星国际(00656.HK)5月4日耗资647.5万港元回购69.5万股

昊海生物科技(06826.HK)5月4日耗资369.5万港元回购10万股H股

康臣药业(01681.HK)5月4日耗资313.4万港元回购79万股

中国星集团(00326.HK)5月4日耗资350万港元回购200万股

天誉置业(00059.HK)5月4日耗资166.62万港元回购165万股

国泰君安国际(01788.HK)5月4日耗资49.2万港元回购50万股

中粮包装(00906.HK)5月4日耗资378.7万港元回购137.4万股

远东发展(00035.HK)5月4日耗资45.43万港元回购17万股

艾德韦宣集团(09919.HK)5月4日耗资90.5万港元回购103.6万股

映客(03700.HK)5月4日耗资46.25万港元回购44万股

科通芯城(00400.HK)5月4日耗资50.63万港元回购62.5万股

【股权激励】

雷蛇(01337.HK)授出2772.7万个受限制股份单位

隽泰控股(00630.HK)授出1.86亿份购股权

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account